Orbit Genomics
PrivateLast Round
Grant
Sep 24, 2024
Est. Valuation
$4.07M
Total Funding Raised
$6.85M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Orbit Genomics is a biotechnology company that develops an AI-enabled genomic analysis platform for the diagnosis, treatment, and prevention of complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orbit Genomics Comparables
Compare Orbit Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Singlera Genomics Inc. | 76% | |
| Biodesix Inc | 73% | |
| Lucence | 73% |
Orbit Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 24, 2024 | ||||
| Early Funding | Jul 29, 2024 | ||||
| Series A | Jan 6, 2022 | ||||
| Grant | May 20, 2021 | ||||
| Accelerator | Oct 30, 2019 |
Orbit Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Plug and Play Tech Center | Accelerator |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 65% MoM, from 1.2K to 2K.
- Jun 18, 2026
Monthly visitors grew 50% MoM.
Orbit Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Orbit Genomics's valuation, stock price, and market status.
Is Orbit Genomics a public or private company?
Orbit Genomics is a private company.
What is the current stock price of Orbit Genomics?
Orbit Genomics is a private company with no public stock price. Caplight tracks Orbit Genomics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Orbit Genomics worth (valuation)?
Orbit Genomics's valuation is estimated at $4.1M based on funding round data.
Can I buy Orbit Genomics stock?
Orbit Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Orbit Genomics's last funding round?
Orbit Genomics's most recent funding round was Grant on January 6, 2022.
Who are the main investors in Orbit Genomics?
Key investors in Orbit Genomics include National Cancer Institute, Plug and Play Tech Center, National Institutes of Health (NIH).
Will Orbit Genomics IPO soon?
No public IPO plans have been announced for Orbit Genomics.
How can I track Orbit Genomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Orbit Genomics's secondary market activity and sign up for updates.